Home > Insider Trading > Filing (0001213900-21-051646)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1513525	Adial Pharmaceuticals Inc.	ADIL	Pharmaceutical Preparations (2834)	800667150

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1718158	A. Bankole Johnson	525 Melaeuca Lane Miami FL 33137	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-10-04	200,000	$0.00	148,246	No	4	S	Indirect	By En Fideicomiso De Mi Vida 11/23/2010 (Trust)

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By En Fideicomiso De Mi Vida 11/23/2010 (Trust)

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant	Disposition	2021-10-04	150,000	$0.00	150,000	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
39,714			No	4	J	Direct

Footnotes

En Fideicomiso De Mi Vida 11/23/2010 (the "Trust") sold 200,000 shares of the issuer's common stock pursuant to a Stock Purchase Agreement dated as of October 1, 2021 (the "SPA"), for an aggregate purchase price of $200,000.
Dr. Johnson is the trustee of the Trust.
On October 4, 2021, Dr. Johnson sold warrants to purchase 150,000 shares of the issuer's common stock pursuant to the SPA, for an aggregate purchase price of $1,500. The warrants provide for an exercise price of $6.25 per share and expire five years after issuance.